AAAAAA
Results:
1-15
|
Results: 15
Authors:
VUCENIK I
KALEBIC T
TANTIVEJKUL K
SHAMSUDDIN AM
Citation: I. Vucenik et al., NOVEL ANTICANCER FUNCTION OF INOSITOL HEXAPHOSPHATE - INHIBITION OF HUMAN RHABDOMYOSARCOMA IN-VITRO AND IN-VIVO, Anticancer research, 18(3A), 1998, pp. 1377-1384
Authors:
KALEBIC T
Citation: T. Kalebic, HIV VACCINE TRIALS, Science, 279(5356), 1998, pp. 1434-1435
Authors:
KALEBIC T
BLAKESLEY V
SLADE C
PLASSCHAERT S
LEROITH D
HELMAN LJ
Citation: T. Kalebic et al., EXPRESSION OF A KINASE-DEFICIENT IGF-I-R SUPPRESSES TUMORIGENICITY OFRHABDOMYOSARCOMA CELLS CONSTITUTIVELY EXPRESSING A WILD-TYPE IGF-I-R, International journal of cancer, 76(2), 1998, pp. 223-227
Authors:
BLAKESLEY VA
STANNARD BS
KALEBIC T
HELMAN LJ
LEROITH D
Citation: Va. Blakesley et al., ROLE OF THE IGF-I RECEPTOR IN MUTAGENESIS AND TUMOR PROMOTION, Journal of Endocrinology, 152(3), 1997, pp. 339-344
Authors:
TORETSKY JA
KALEBIC T
BLAKESLEY V
LEROITH D
HELMAN LJ
Citation: Ja. Toretsky et al., THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR IS REQUIRED FOR EWS FLI-1 TRANSFORMATION OF FIBROBLASTS/, The Journal of biological chemistry, 272(49), 1997, pp. 30822-30827
Authors:
KALEBIC T
JUDDE JG
VELEZYANGUAS M
KNUTSEN T
HELMAN LJ
Citation: T. Kalebic et al., METASTATIC HUMAN RHABDOMYOSARCOMA - MOLECULAR, CELLULAR AND CYTOGENETIC ANALYSIS OF A NOVEL CELLULAR-MODEL, Invasion & metastasis, 16(2), 1996, pp. 83-96
Authors:
VELEZYANGUAS MC
KALEBIC T
MAGGI M
KAPPEL CC
LETTERIO J
USKOKOVIC M
HELMAN LJ
Citation: Mc. Velezyanguas et al., ROXY-16-ENE-23-YNE-26,27-HEXAFLUOROCHOLECALCIFEROL (RO24-5531) MODULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 AND INDUCTION OF DIFFERENTIATION AND GROWTH ARREST IN A HUMAN OSTEOSARCOMA CELL-LINE, The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 93-99
Authors:
KALEBIC T
TSOKOS M
HELMAN LJ
Citation: T. Kalebic et al., SUPPRESSION OF RHABDOMYOSARCOMA GROWTH BY FUMAGILLIN ANALOG TNP-470, International journal of cancer, 68(5), 1996, pp. 596-599
Authors:
KALEBIC T
Citation: T. Kalebic, HUMAN FETAL GLIAL-CELLS CONSTITUTIVELY PRODUCE HIV-INDUCING CYTOKINES, Experimental cell research, 223(2), 1996, pp. 452-458
Authors:
BLAKESLEY VA
KALEBIC T
HELMAN LJ
STANNARD B
FARIA TN
ROBERTS CT
LEROITH D
Citation: Va. Blakesley et al., TUMORIGENIC AND MITOGENIC CAPACITIES ARE REDUCED IN TRANSFECTED FIBROBLASTS EXPRESSING MUTANT INSULIN-LIKE GROWTH-FACTOR (IGF)-I RECEPTORS - THE ROLE OF TYROSINE RESIDUE-1250, RESIDUE-1251, AND RESIDUE-1316 INTHE CARBOXY-TERMINUS OF THE IGF-I RECEPTOR, Endocrinology, 137(2), 1996, pp. 410-417
Authors:
HERNANDEZSANCHEZ C
BLAKESLEY V
KALEBIC T
HELMAN L
LEROITH D
Citation: C. Hernandezsanchez et al., THE ROLE OF THE TYROSINE KINASE DOMAIN OF THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR IN INTRACELLULAR SIGNALING, CELLULAR PROLIFERATION AND TUMORIGENESIS, The Journal of biological chemistry, 270(49), 1995, pp. 29176-29181
Authors:
KALEBIC T
SCHEIN PS
Citation: T. Kalebic et Ps. Schein, ORGANIC THIOPHOSPHATE WR-151327 SUPPRESSES EXPRESSION OF HIV IN CHRONICALLY INFECTED-CELLS, AIDS research and human retroviruses, 10(6), 1994, pp. 727-733
Authors:
KALEBIC T
TSOKOS M
HELMAN LJ
Citation: T. Kalebic et al., IN-VIVO TREATMENT WITH ANTIBODY AGAINST IGF-1 RECEPTOR SUPPRESSES GROWTH OF HUMAN RHABDOMYOSARCOMA AND DOWN-REGULATES P34(CDC2), Cancer research, 54(21), 1994, pp. 5531-5534
Authors:
KALEBIC T
TSOKOS M
HELMAN LJ
Citation: T. Kalebic et al., IN-VIVO TREATMENT WITH ANTIBODY AGAINST IGF-1 RECEPTOR SUPPRESSES GROWTH OF HUMAN RHABDOMYOSARCOMA AND DOWN-REGULATES P34(CDC2), Cancer research, 54(21), 1994, pp. 5531-5534
Authors:
KALEBIC T
MASIERO L
ONISTO M
GARBISA S
Citation: T. Kalebic et al., HIV-1 MODULATES THE EXPRESSION OF GELATINASE-A AND GELATINASE-B IN MONOCYTIC CELLS, Biochemical and biophysical research communications, 205(2), 1994, pp. 1243-1249
Risultati:
1-15
|